JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dyer, C. A.
Right arrow Articles by Curtiss, L. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dyer, C. A.
Right arrow Articles by Curtiss, L. K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J. Biol. Chem., Vol. 266, Issue 23, 15009-15015, Aug, 1991

Only multimers of a synthetic peptide of human apolipoprotein E are biologically active

CA Dyer, RS Smith and LK Curtiss
Department of Immunology, Research Institute of Scripps Clinic, La Jolla, California 92037.

Plasma apolipoprotein E (apoE) is a ligand for the cellular uptake of cholesterol-rich plasma lipoproteins. ApoE also inhibits mitogen- stimulated lymphocyte proliferation and gonadotropin-stimulated ovarian theca/interstitial cell androgen production. To address the mechanism(s) by which apoE is active and to understand its interaction with the target cells, we prepared and examined the inhibitory activity of a series of apoE synthetic peptides. ApoE peptides representing amino acid residues 93-112, 141-155, 161-171, 172-182, and 174-193 were not active in either bioassay. However, specific inhibition of both lymphocyte proliferation and ovarian androgen production was observed with a self-conjugate of peptide-(141-155). Furthermore, a synthesized dimeric peptide representing two repeats of sequence-(141-155) (i.e. (141-155)-(141-155] was active as well. In both bioassays, the inhibition observed was not a result of direct cell killing. Furthermore, these apoE peptides exhibited activities with characteristics that were shared with those of native apoE. The results indicate that amino acid residues 141-155 of apoE are responsible for the biological activity of apoE. Furthermore, the results suggest that dimers or multimers of native apoE may be a biologically important species.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
H. Saito, P. Dhanasekaran, D. Nguyen, F. Baldwin, K. H. Weisgraber, S. Wehrli, M. C. Phillips, and S. Lund-Katz
Characterization of the Heparin Binding Sites in Human Apolipoprotein E
J. Biol. Chem., April 18, 2003; 278(17): 14782 - 14787.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
G. Datta, D. W. Garber, B. H. Chung, M. Chaddha, N. Dashti, W. A. Bradley, S. H. Gianturco, and G. M. Anantharamaiah
Cationic domain 141-150 of apoE covalently linked to a class A amphipathic helix enhances atherogenic lipoprotein metabolism in vitro and in vivo
J. Lipid Res., June 1, 2001; 42(6): 959 - 966.
[Abstract] [Full Text]


Home page
J. Lipid Res.Home page
H. Liu, C. Labeur, C.-F. Xu, R. Ferrell, L. Lins, R. Brasseur, M. Rosseneu, K. M. Weiss, S. E. Humphries, and P. J. Talmud
Characterization of the lipid-binding properties and lipoprotein lipase inhibition of a novel apolipoprotein C-III variant Ala23Thr
J. Lipid Res., November 1, 2000; 41(11): 1760 - 1771.
[Abstract] [Full Text]


Home page
Biol. Reprod.Home page
C. V. Zerbinatti and C. A. Dyer
Apolipoprotein E Peptide Stimulation of Rat Ovarian Theca Cell Androgen Synthesis Is Mediated by Members of the Low Density Lipoprotein Receptor Superfamily
Biol Reprod, September 1, 1999; 61(3): 665 - 672.
[Abstract] [Full Text]


Home page
J. Lipid Res.Home page
W. A. Boisvert and L. K. Curtiss
Elimination of macrophage-specific apolipoprotein E reduces diet-induced atherosclerosis in C57BL/6J male mice
J. Lipid Res., May 1, 1999; 40(5): 806 - 813.
[Abstract] [Full Text]


Home page
J. Lipid Res.Home page
G. Zhang, L. K. Curtiss, R. L. Wade, and C. A. Dyer
An apolipoprotein E synthetic peptide selectively modulates the transcription of the gene for rat ovarian theca and interstitial cell P450 17{alpha}-hydroxylase, C17–20 lyase
J. Lipid Res., December 1, 1998; 39(12): 2406 - 2414.
[Abstract] [Full Text]


Home page
J. Lipid Res.Home page
S. E. Roselaar and A. Daugherty
Apolipoprotein E-deficient mice have impaired innate immune responses to Listeria monocytogenes in vivo
J. Lipid Res., September 1, 1998; 39(9): 1740 - 1743.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
M. Tolar, M. A. Marques, J. A. K. Harmony, and K. A. Crutcher
Neurotoxicity of the 22 kDa Thrombin-Cleavage Fragment of Apolipoprotein E and Related Synthetic Peptides Is Receptor-Mediated
J. Neurosci., August 1, 1997; 17(15): 5678 - 5686.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. K. Swertfeger and D. Y. Hui
Apolipoprotein E Receptor Binding Versus Heparan Sulfate Proteoglycan Binding in Its Regulation of Smooth Muscle Cell Migration and Proliferation
J. Biol. Chem., June 29, 2001; 276(27): 25043 - 25048.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1991 by the American Society for Biochemistry and Molecular Biology.